<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s12879-019-4522-1</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">12879</journal-id><journal-title-group><journal-title>BMC Infectious Diseases</journal-title><abbrev-journal-title abbrev-type="publisher">BMC Infect Dis</abbrev-journal-title></journal-title-group><issn pub-type="epub">1471-2334</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s12879-019-4522-1</article-id><article-id pub-id-type="manuscript">4522</article-id><article-id pub-id-type="doi">10.1186/s12879-019-4522-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="article-collection" specific-use="SubjectSection"><subject>Bacterial and fungal diseases</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Chromosomal and plasmid-mediated fluoroquinolone resistance in human <italic>Salmonella enterica</italic> infection in Ghana</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Acheampong</surname><given-names>Godfred</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Owusu</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Owusu-Ofori</surname><given-names>Alex</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Osei</surname><given-names>Isaac</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Sarpong</surname><given-names>Nimako</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" id="Au6"><name><surname>Sylverken</surname><given-names>Augustina</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" id="Au7"><name><surname>Kung</surname><given-names>Hung-Jui</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author" id="Au8"><name><surname>Cho</surname><given-names>Shu-Ting</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author" id="Au9"><name><surname>Kuo</surname><given-names>Chih-Horng</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author" id="Au10"><name><surname>Park</surname><given-names>Se Eun</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author" id="Au11"><name><surname>Marks</surname><given-names>Florian</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author" id="Au12"><name><surname>Adu-Sarkodie</surname><given-names>Yaw</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au13"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4232-4292</contrib-id><name><surname>Owusu-Dabo</surname><given-names>Ellis</given-names></name><xref ref-type="aff" rid="Aff10">10</xref><xref ref-type="corresp" rid="IDs1287901945221_cor13">p</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.487281.0</institution-id><institution content-type="org-name">Kumasi Centre for Collaborative Research in Tropical Medicine</institution></institution-wrap><addr-line content-type="city">Kumasi</addr-line><country country="GH">Ghana</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000109466120</institution-id><institution-id institution-id-type="GRID">grid.9829.a</institution-id><institution content-type="org-division">Department of Medical Laboratory Technology</institution><institution content-type="org-name">Kwame Nkrumah University of Science and Technology</institution></institution-wrap><addr-line content-type="city">Kumasi</addr-line><country country="GH">Ghana</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000000109466120</institution-id><institution-id institution-id-type="GRID">grid.9829.a</institution-id><institution content-type="org-division">Department of Clinical Microbiology</institution><institution content-type="org-name">Kwame Nkrumah University of Science and Technology</institution></institution-wrap><addr-line content-type="city">Kumasi</addr-line><country country="GH">Ghana</country></aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0466 0719</institution-id><institution-id institution-id-type="GRID">grid.415450.1</institution-id><institution content-type="org-name">Komfo Anokye Teaching Hospital</institution></institution-wrap><addr-line content-type="city">Kumasi</addr-line><country country="GH">Ghana</country></aff><aff id="Aff5"><label>5</label><institution-wrap><institution content-type="org-name">Agogo Presbyterian Hospital</institution></institution-wrap><addr-line content-type="city">Agogo</addr-line><country country="GH">Ghana</country></aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000000109466120</institution-id><institution-id institution-id-type="GRID">grid.9829.a</institution-id><institution content-type="org-division">Department of Theoretical and Applied Biology</institution><institution content-type="org-name">Kwame Nkrumah University of Science and Technology</institution></institution-wrap><addr-line content-type="city">Kumasi</addr-line><country country="GH">Ghana</country></aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2287 1366</institution-id><institution-id institution-id-type="GRID">grid.28665.3f</institution-id><institution content-type="org-name">Institute of Plant and Microbial Biology, Academia Sinica</institution></institution-wrap><addr-line content-type="city">Taipei</addr-line><country country="TW">Taiwan</country></aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9629 885X</institution-id><institution-id institution-id-type="GRID">grid.30311.30</institution-id><institution content-type="org-division">Department of Epidemiology</institution><institution content-type="org-name">International Vaccine Institute</institution></institution-wrap><addr-line content-type="city">Seoul</addr-line><country country="KR">South Korea</country></aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0429 6814</institution-id><institution-id institution-id-type="GRID">grid.412433.3</institution-id><institution content-type="org-name">Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme</institution></institution-wrap><addr-line content-type="street">764 Vo Van Kiet, Quant 5</addr-line><addr-line content-type="city">Ho Chi Minh City</addr-line><country country="VN">Vietnam</country></aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000000109466120</institution-id><institution-id institution-id-type="GRID">grid.9829.a</institution-id><institution content-type="org-division">Department of Global and International Health, School of Public Health</institution><institution content-type="org-name">Kwame Nkrumah University of Science and Technology</institution></institution-wrap><addr-line content-type="city">Kumasi</addr-line><country country="GH">Ghana</country></aff></contrib-group><author-notes><corresp id="IDs1287901945221_cor13"><label>p</label><email>owusudabo@yahoo.com</email><email>eowusu-dabo.chs@knust.edu.gh</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>10</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>19</volume><issue seq="889">1</issue><elocation-id>898</elocation-id><history><date date-type="registration"><day>30</day><month>9</month><year>2019</year></date><date date-type="received"><day>2</day><month>7</month><year>2019</year></date><date date-type="accepted"><day>30</day><month>9</month><year>2019</year></date><date date-type="online"><day>28</day><month>10</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s). 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="url">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><sec id="ASec1"><title>Background</title><p id="Par1"><italic>Salmonella</italic> infection poses significant public health threat globally, especially in resource-limited countries. Emergence and spread of antibiotic resistant strains to fluoroquinolones have led to treatment failures and increased mortality in <italic>Salmonella</italic> infection. However, there is dearth of information regarding mechanisms of resistance to fluoroquinolones in Ghana. This study therefore sought to identify chromosomal mutations and plasmid-mediated resistance as possible mechanisms of fluoroquinolone resistance from clinical isolates in Ghana.</p></sec><sec id="ASec2"><title>Methods</title><p id="Par2">This was a retrospective study of archived isolates biobanked at Kumasi Centre for Collaborative Research in Tropical Medicine, Ghana. Isolates were obtained from blood, stool and oropharynx samples at two hospitals, between May, 2016 and January, 2018. <italic>Salmonella</italic> identification was done using standard microbiological protocols and antibiotic susceptibility testing performed by Kirby-Bauer disc diffusion method. Isolates with intermediate susceptibility and/or resistance to nalidixic acid and/or ciprofloxacin were selected and examined for chromosomal mutations by Sanger sequencing and plasmid-mediated resistance by PCR.</p></sec><sec id="ASec3"><title>Results</title><p id="Par3">Of 133 biobanked isolates cultured, 68 (51.1%) and 16 (12%) were identified as <italic>Salmonella</italic> Typhi and non-typhoidal <italic>Salmonella</italic> (NTS), respectively. Sequence analysis of <italic>gyrA</italic> gene revealed the presence of 5 different nonsynonymous mutations, with the most frequent mutation (Ile203Ser) occurring in 12 out of 13 isolates tested. Gyrase B (<italic>gyrB</italic>) gene had 1 nonsynonymous mutation in 3 out of 13 isolates, substituting phenylalanine with leucine at codon 601 (Phe601Leu). No mutation was observed in <italic>parC</italic> and <italic>parE</italic> genes. Two NTS isolates were found to harbour <italic>qnrS</italic> plasmid-mediated resistant gene of molecular size 550 bp with high ciprofloxacin MIC of 0.5 μg/ml.</p></sec><sec id="ASec4"><title>Conclusion</title><p id="Par4">This study reports for the first time in Ghana plasmid-mediated fluoroquinolone resistant gene <italic>qnrS</italic> in <italic>Salmonella</italic> clinical isolates. Nonsynonymous mutations of <italic>gyrA</italic> and <italic>gyrB</italic> genes likely to confer <italic>Salmonella</italic> reduced susceptibility to ciprofloxacin were also reported.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Fluoroquinolone resistance</kwd><kwd>Plasmids</kwd><kwd><italic>Salmonella enterica</italic></kwd><kwd>Mutations</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Bill and Melinda Gates Foundation</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/100000865</institution-id></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>KNUST Resarch Fund</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>2</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>9</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>30</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/12879_2019_Article_4522.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Medicine &amp; Public Health</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Infectious Diseases</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Parasitology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Medical Microbiology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Tropical Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Internal Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Medicine</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par24">Human <italic>Salmonella enterica</italic> infection poses a significant public-health challenge globally, especially in low-to-middle income countries in sub-Saharan Africa and South Asia where sanitation is poor [<xref ref-type="bibr" rid="CR1">1</xref>]. The situation is worsened by an increasing rate of emergence and distribution of antibiotic resistant strains [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]<italic>.</italic></p><p id="Par25">One surveillance study has demonstrated an obvious increase in overall antimicrobial resistance from 20 to 30% in the early 1990s to as high as 70% in the early 2000s [<xref ref-type="bibr" rid="CR5">5</xref>]. This report was based on old generic antibiotics which are not currently in use. Chloramphenicol, ampicillin and sulfamethoxazole trimethoprim used to be the drugs of choice for treating <italic>Salmonella</italic> infection for over a decade [<xref ref-type="bibr" rid="CR6">6</xref>] . However, because of increased resistance to these first-line drugs, physicians have resorted to ciprofloxacin (a fluoroquinolone) [<xref ref-type="bibr" rid="CR7">7</xref>]. Since its introduction, there has not been structured surveillance mechanism(s) to identify mutations possibly associated with its resistance in Ghana. Availability of only few new antibiotics, has placed enormous value on investigations into resistance strains of bacteria. The World Health Organisation (WHO) has listed fluoroquinolone–resistant <italic>Salmonella</italic> spp. as part of the priority pathogens for which new antibiotics are urgently needed [<xref ref-type="bibr" rid="CR8">8</xref>]. Although phenotypic resistance could be available in some clinical laboratories, there is paucity of data on molecular investigations of fluoroquinolone resistant genes associated with <italic>Salmonella</italic> infection in Ghana and many African countries.</p><p id="Par26">Fluoroquinolone resistance is mainly due to two mechanisms: chromosomally mediated mutations occurring at the quinolone resistance determining regions (QRDR) of topoisomerase genes (<italic>gyrA, gyrB, parC</italic> and <italic>parE</italic> genes) and resistance mediated by plasmids [<xref ref-type="bibr" rid="CR9">9</xref>]. The latter is further divided into 3 different routes that confer decreased susceptibility to fluoroquinolones: 1) quinolone resistance proteins (encoded by <italic>qnr</italic> genes (<italic>qnrA, qnrB, qnrC, qnrD, qnrS</italic>) that shield DNA gyrase from the effect of fluoroquinolones); 2) aac(6′)-Ib-cr resistance mechanism (an aminoglycoside acetyltransferase that modifies fluoroquinolones by acetylating the free nitrogen on the C7 ring of the drug, decreasing binding affinity), and 3) plasmid-mediated resistance by OqxAb and QepA efflux systems [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par27">Fluoroquinolones resistance mediated by plasmids have been identified in some developed countries such as United States of America, United Kingdom and France [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. With the high rate of spread of plasmid-mediated resistance determinants coupled with some factors such as international travels, there is a possibility of fluoroquinolone resistant <italic>Salmonella</italic> strains circulating in Ghana. More often than not, fluoroquinolone resistance in <italic>Salmonella enterica</italic> is mediated by <italic>gyrA</italic> mutations [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], with few reported cases of <italic>gyrB</italic> mutations [<xref ref-type="bibr" rid="CR15">15</xref>] and very few cases of topoisomerase IV (<italic>parC</italic> and <italic>parE</italic>) genes. Mutation results in a significant reduction of the drug-enzyme binding, and as such the ability for fluoroquinolones to inhibit DNA ligation is totally restricted [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Both chromosomal and plasmid-encoded fluoroquinolone resistance are responsible for conferring low-level resistance to fluoroquinolones [<xref ref-type="bibr" rid="CR18">18</xref>], nonetheless, high level-resistance (with increasing MIC up to 250-fold) has been documented [<xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par28">Fluoroquinolone resistant <italic>Salmonella</italic> strains with multiple gyr and par mutations have been reported from Cambodia, India and Nepal [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. In Africa, fluoroquinolone resistant strains of <italic>Salmonella</italic> are known to circulate in countries such as Kenya, Tanzania, Malawi, South Africa, Zambia, Democratic Republic of Congo and Nigeria [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. However, meta analysis conducted by Cuypers et al.<italic>,</italic> revealed lower prevalence and spread of these strains in Africa compared to Asia [<xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par29">This study therefore sought to identify resistance associated with mutations in the topoisomerase genes of <italic>Salmonella</italic> and plasmid-mediated resistant genes associated with fluoroquinolone resistance in <italic>Salmonella</italic> strains from Ghana.</p></sec><sec id="Sec2" sec-type="methods"><title>Methods</title><sec id="Sec3"><title>Study design and study area</title><p id="Par30">This was a retrospective study of archived isolates (from blood, stool and oropharynx samples) biobanked at Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Ghana, between May, 2016 and January, 2018. These isolates were collected as part of a larger study that sought to investigate the burden of severe typhoid in sub-Saharan Africa with six countries in participation (Ghana, Burkina Faso, Democratic Republic of Congo, Ethiopia, Nigeria and Madagascar). Nonetheless, this report focused only on the Ghanaian site. Study population comprised patients that presented with fever at Komfo Anokye Teaching Hospital (KATH) and Agogo Presbyterian Hospital (APH) in the Kumasi Metropolis and Asante-Akim North district, respectively, both located in the middle belt of Ghana. KATH serve as a tertiary hospital in an urban setting whereas APH is a primary health facility in a rural area of Ghana.</p></sec><sec id="Sec4"><title>Ethics approval</title><p id="Par31">The main study protocol was reviewed and approved by the Committee for Human Research Publications and Ethics (CHRPE) at the School of Medical Sciences, Kwame Nkrumah University of Science and Technology (KNUST) (Approval Number: CHRPE/AP/188/18).</p></sec><sec id="Sec5"><title>Data collection</title><p id="Par32">Study participants’ biodata such as age and gender were collected from the data department of KCCR. Information regarding the source of isolates, total number of samples received and processed were retrieved from laboratory data.</p></sec><sec id="Sec6"><title>Laboratory procedures</title><sec id="Sec7"><title>Bacterial culture</title><p id="Par33">Biobanked isolates were removed from − 80 °C freezer (Thermo Scientific), thawed and sub-cultured unto three standard growth media: Blood Agar (BA – Columbia agar base supplemented with 5% sheep blood), chocolate agar (CA) and macConkey agar (Mac) (BD, Franklin Lakes, New Jersey, USA) under sterile working condition. All the plates were incubated aerobically overnight at 35 °C–37 °C except for CA plates which was incubated in 5% CO<sub>2</sub> for microaerophilic condition.</p></sec><sec id="Sec8"><title>Bacterial identification</title><p id="Par34"><italic>Salmonella</italic> was identified based on colonial morphology on the various agar, microscopic presentation, latex agglutination test, biochemical tests (including API20E), as well as serotyping (by White-Kauffmann Le-Minor scheme) using commercially available serotyping kit from BD (Franklin Lakes, New Jersey, USA). On both the BA and CA, small, creamy gamma (ɣ) hemolytic colonies consistent with <italic>Salmonella</italic> sp. was recorded. Gram negative short rods with small colourless non-lactose fermenting colonies on Mac was also documented. Biochemical tests such as triple sugar iron (TSI), urease, citrate tests were performed to aid in <italic>Salmonella</italic> identification from other enterobacteria based on sugars fermentation, urease production and citrate utilisation, respectively. Isolation and identification of other gram negative and positive bacteria were done according to standard microbiological protocols.</p></sec><sec id="Sec9"><title>Antibiotic susceptibility testing</title><p id="Par35">We performed antimicrobial susceptibility testing on all biobanked isolates confirmed as <italic>Salmonella</italic> according to Clinical and Laboratory Standards Institute (CLSI) guidelines [<xref ref-type="bibr" rid="CR24">24</xref>]. Susceptibility to ampicillin (10 μg), amoxiclav (amoxicillin &amp; clavulanic acid; 20/10 μg), ceftriaxone (30 μg), trimethoprim/sulfamethoxazole (1.25/23.75 μg), ciprofloxacin (5 μg), gentamicin (10 μg), tetracycline (30 μg), chloramphenicol (30 μg), ceftazidime (30 μg), cefotaxime (30 μg) and nalidixic acid (30 μg) was tested on Mueller Hinton agar (BD, USA) using the Kirby-Bauer disc diffusion method. The breakpoints of the various antibiotics used were in line with CLSI 2018. Resistance to fluoroquinolones, defined as isolates with intermediate susceptibility and/or resistance to nalidixic acid (surrogate marker for ciprofloxacin resistance) and/or ciprofloxacin were selected for Minimum Inhibitory Concentration (MIC). Enterobacteria such as <italic>E. coli</italic> and <italic>Klebsiella</italic> sp. that were resistant to 3rd generation cephalosporins in this study were further screened to detect the presence of extended spectrum beta-lactamase (ESBL) enzyme using double-disc diffusion method on Mueller Hinton agar according to CLSI guidelines [<xref ref-type="bibr" rid="CR24">24</xref>]. Again, <italic>S. aureus</italic> resistant to cefoxitin were regarded as methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA).</p></sec><sec id="Sec10"><title>MIC determination</title><p id="Par36">Minimum inhibitory concentration (MIC) was performed on ciprofloxacin/nalidixic acid intermediate and/or resistant isolates using ciprofloxacin E-test (epsilometer test) according to the manufacturers recommendation (Oxoid, Wesel, Germany) to confirm ciprofloxacin resistance. E-test gives a direct quantification of antimicrobial susceptibility in the form of discrete MIC values. Isolates with ciprofloxacin breakpoint concentration (μg/ml) of ≤0.06 μg/ml was documented as sensitive (S); between 0.12 and 0.5 μg/ml as intermediate (I); and ≥ 1 μg/ml was reported as resistant (R) following the CLSI guidelines.</p></sec><sec id="Sec11"><title>Quality control</title><p id="Par37"><italic>Escherichia coli</italic> ATCC 25922 and <italic>Salmonella</italic> Typhimurium ATCC 14028 were set up together with the test organisms to control media, biochemical tests, potency of antibiotic discs, and ciprofloxacin E-test strip.</p></sec></sec><sec id="Sec12"><title>Molecular detection of fluoroquinolone resistant genes</title><sec id="Sec13"><title>DNA extraction</title><p id="Par38">Genomic DNA was extracted from ciprofloxacin and/or nalidixic acid resistant and/or intermediate isolates using spherolyse DNA isolation kit (HainLife Science, Nehren, Germany) according to manufacturer’s instructions. Extracted DNA were used as templates for detection of chromosomally-encoded mutations in the topoisomerase genes and plasmid-mediated fluoroquinolone resistant genes.</p></sec><sec id="Sec14"><title>Amplification of topoisomerase genes</title><p id="Par39">Detection and amplification of <italic>gyrA, gyrB, parC</italic> and <italic>parE</italic> genes by PCR was performed using primers shown in Table <xref rid="Tab1" ref-type="table">1</xref>. Twenty-five microlitres of One Taq Quick-Load 2x Master Mix with standard buffer (New England Biolabs® Inc) was added to 1 μl each of 10 μM forward and reverse primers respectively. Twenty-two microlitres of nuclease-free water was added to the mastermix and finally, 1 μl DNA template to obtain a reaction volume of 50 μl.
<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Sequence of primers for detection of <italic>gyrA, gyrB, parC</italic> and <italic>parE</italic> genes</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Target gene</p></th><th><p>Nucleotide sequence (5′ -3′)</p></th><th><p>Product size (bp)</p></th><th><p>References</p></th></tr></thead><tbody><tr><td rowspan="2"><p><italic>GyrA</italic></p></td><td><p>F 5′ –ATGAGCGACCTTGCGAGAGAGAAATACACCG − 3′</p></td><td char="." align="char" rowspan="2"><p>632</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR25">25</xref>]</p></td></tr><tr><td><p>R 5′ – TTCCATCAGCCCTTCAATGCTGAGTCTTC − 3′</p></td></tr><tr><td rowspan="2"><p><italic>GyrB</italic></p></td><td><p>F 5′ – AAGCGCGATGGCAAAGAAG − 3′</p></td><td char="." align="char" rowspan="2"><p>1500</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR25">25</xref>]</p></td></tr><tr><td><p>R 5′ – AACGGTCTGCTCATCAGAAAGG − 3′</p></td></tr><tr><td rowspan="2"><p><italic>ParC</italic></p></td><td><p>F 5′- CTATGCGATGTCAGAGCTGG − 3′</p></td><td char="." align="char" rowspan="2"><p>270</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR26">26</xref>]</p></td></tr><tr><td><p>R 5′- TAACAGCAGCTCGGCGTATT − 3′</p></td></tr><tr><td rowspan="2"><p><italic>ParE</italic></p></td><td><p>F 5′- TCTCTTCCGATGAAGTGCTG − 3′</p></td><td char="." align="char" rowspan="2"><p>240</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR26">26</xref>]</p></td></tr><tr><td><p>R 5′- ATACGGTATAGCGGCGGTAG − 3′</p></td></tr></tbody></table></table-wrap></p><p id="Par40">Amplification using Veriti thermal cycler was conducted using the following PCR cycling condition: an initial denaturation at 94.0 °C for 30 s; 30 cycles of 94.0 °C for 30 s, *60/54/53/52 °C for 1 min and 68.0 °C for 1 min with a final extension of 68.0 °C for 5 min. The reaction was put on hold at 4 °C until attended to.</p><p id="Par41"><bold><italic>Note: *60/54/53/52 °C</italic></bold><italic>corresponds to annealing temperatures of gyrA, gyrB, parC and parE genes, respectively.</italic></p></sec><sec id="Sec15"><title>PCR product purification</title><p id="Par42">The products of amplification of <italic>gyrA, gyrB, parC</italic> and <italic>parE</italic> genes were purified using DNA clean and concentrator™-25 kit (Zymo research, Irvine, USA) according to manufacturer’s instruction. This was to ensure that ultra-pure PCR products are recovered ahead of Sanger sequencing.</p></sec><sec id="Sec16"><title>DNA sequencing and analysis of mutation</title><p id="Par43">Sanger sequencing of the purified PCR products was achieved using the aforementioned primers of the topoisomerase genes on an ABI 3730XL DNA Analyzer. Analysis of the DNA sequences was performed by comparing with the reference <italic>S</italic>. Typhimurium strain LT2 genome (accession number AE006468.2) for <italic>gyrA</italic>, <italic>gyrB</italic>, <italic>parC</italic> and <italic>parE genes</italic> (accession numbers AAL21173.1, AAL22694.1, AAL22048.1 and AAL22055.1, respectively) at GenBank database using the NCBI (National Centre for Biotechnology Information) BLAST (basic local alignment search tool) program. ExPASy (<bold>Ex</bold>pert <bold>P</bold>rotein <bold>A</bold>nalysis <bold>Sy</bold>stem) translate tool, SIB (Swiss Institute of Bioinformatics) was used to translate the nucleotide sequences into amino acid sequences. Global alignment tool EBI (European Bioinformatics Institute) was used to investigate for any mutations using Needleman-Wunsch algorithm (EMBOSS).</p></sec><sec id="Sec17"><title>Detection of plasmid-mediated quinolonone resistance genes (PMQR)</title><p id="Par44">Polymerase chain reaction (PCR) amplification of fluoroquinolones resistant genes: <italic>qnrA, qnrB</italic> and <italic>qnrS</italic> was performed on all <italic>Salmonella</italic> isolates using the primers [<xref ref-type="bibr" rid="CR9">9</xref>] in Table <xref rid="Tab2" ref-type="table">2</xref>. Genomic DNA extraction and PCR master-mix preparation were prepared as mentioned before.
<table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>Primers used for amplification of PMQR genes</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Name</p></th><th><p>Sequence</p></th><th><p>Size (bp)</p></th><th><p>References</p></th></tr></thead><tbody><tr><td><p>QnrA-FW</p></td><td><p>5′-GGGTAT GGATATTATTGATAAAG-3′</p></td><td char="." align="char" rowspan="2"><p>660</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR9">9</xref>]</p></td></tr><tr><td><p>QnrA-RV</p></td><td><p>5′-CTAATCCG GCAGCACTATTA-3′</p></td></tr><tr><td><p>QnrB-FW</p></td><td><p>5′-GGMATHGAAATTCGCCACTG-3′</p></td><td char="." align="char" rowspan="2"><p>264</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR9">9</xref>]</p></td></tr><tr><td><p>QnrB-RV</p></td><td><p>5′-TTTGCYGYYCGCCAGTCGAA-3′</p></td></tr><tr><td><p>QnrS-FW</p></td><td><p>5′-AGTGATCTCACCTTCACCGC-3′</p></td><td char="." align="char" rowspan="2"><p>550</p></td><td rowspan="2"><p>[<xref ref-type="bibr" rid="CR9">9</xref>]</p></td></tr><tr><td><p>QnrS-RV</p></td><td><p>5′-CAGGCTGCAATTTTGATACC-3′</p></td></tr></tbody></table></table-wrap></p><p id="Par45">PCR experiments were carried out according to the following cycling conditions for all three genes: initial denaturation - 94 °C for 30s; template denaturation - 94 °C for 30s; annealing - 55 °C for 60s; extension - 68 °C for 60s; final extension - 68 °C for 5mins; and reaction was put on hold at 4 °C until amplicons were collected for agarose gel electrophoresis.</p></sec><sec id="Sec18"><title>Gel documentation</title><p id="Par46">The amplicons were resolved by agarose gel electrophoresis (1.5% agarose) at 120 V for an hour and band visualisation done with the aid of UV-transilluminator (Vilber Lourmat, Collegien, France). The concentation of agarose used was more suitable for the expected band sizes in this work. The stained gel was captured unto a desktop computer using the infinity® software.</p></sec></sec><sec id="Sec19"><title>Statistical analysis</title><p id="Par47">Data were entered into Microsoft excel and exported to STATA version 12 (Stata Corp, USA) for analysis. Descriptive statistics was used to summarize the distribution of various variables into tables and graphs. Differences between discrete variables were analysed using Fisher’s exact test.</p></sec></sec><sec id="Sec20" sec-type="results"><title>Results</title><sec id="Sec21"><title>Socio-demographic characteristics of the study population</title><p id="Par48">Majority (402/1036; 38.8% and 251/364; 69.0%) of the sampled population from the two study sites (APH and KATH) were ≤ 5 years old. The overall mean (±SE) age (in years) of participants was 15.4 ± 0.5. The mean (±SE) age (in years) of recruited patients seeking medical attention at APH and KATH was 18.7 ± 0.6 and 4.5 ± 0.2 respectively. At both sites, there were high proportion of males compared to females.</p></sec><sec id="Sec22"><title>Distribution of bacteremic pathogens</title><p id="Par49">Of 133 biobanked isolates cultured, 68 (51.1%) and 16 (12%) were identified as <italic>Salmonella</italic> Typhi and non-typhoidal <italic>Salmonella</italic> (NTS) respectively (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Other bacteriae identified included <italic>Escherichia coli</italic> (including ESBL; 11; 8.3%), <italic>Staphylococcus aureus</italic> (including MRSA; 7; 5.3%) and <italic>Klebsiella pneumoniae</italic> (5; 3.8%)<italic>. Salmonella</italic> Typhi was predominantly found in APH (56/68; 82.4%) while NTS was high in KATH (9/16; 56.3%).
<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>Distribution of bacteremic isolates from study sites. Biobanked bacterial isolates were cultured and identified using standard microbiological culture methods and biochemical tests</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12879_2019_4522_Fig1_HTML.png" id="MO1"/></p></fig></p></sec><sec id="Sec23"><title>Salmonella from stool and oropharynx</title><p id="Par50">A total of 13 <italic>Salmonella</italic> strains were isolated from 418 stool specimens collected from both APH and KATH. Of the 13 strains, 4 (30.8%) and 9 (69.2%) were <italic>S.</italic> Typhi and NTS, respectively (Table <xref rid="Tab3" ref-type="table">3</xref>). <italic>Salmonella</italic> was the only pathogen isolated from stool. Five hundred and fifty eight oropharyngeal specimens (OPS) were collected from the two study sites: APH – 401 (71.9%) and KATH – 157 (28.1%). Of the four (4) <italic>Salmonella</italic> strains isolated from 558 OPS, only 1 (25.0%) was identified as <italic>S</italic>. Typhi and 3 (75.0%) NTS (Table <xref rid="Tab3" ref-type="table">3</xref>). All the <italic>Salmonella</italic> strains isolated from stool and OPS were from APH but not KATH.
<table-wrap id="Tab3"><label>Table 3</label><caption xml:lang="en"><p>Bacterial isolates from stool and oropharynx</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"><p>Pathogen</p></th><th colspan="2"><p>n(%) pathogens from</p></th></tr><tr><th><p>Stool</p></th><th><p>OPS</p></th></tr></thead><tbody><tr><td><p><italic>S</italic>. Typhi</p></td><td><p>4 (30.8)</p></td><td><p>1 (25.0)</p></td></tr><tr><td><p>NTS</p></td><td><p>9 (69.2)</p></td><td><p>3 (75.0)</p></td></tr><tr><td><p>Total</p></td><td><p>13 (100)</p></td><td><p>4 (100)</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec24"><title>Serotyping of bacteremic isolates</title><p id="Par51">Serotyping of iNTS revealed that <italic>Salmonella</italic> Typhimurium (10/16; 62.5%) was the most predominant serovar identified followed by <italic>Salmonella</italic> Enteritidis (5/16; 31.3%) and finally, 1 (1/16; 6.2%) untypable isolate. Rate of isolation of <italic>Salmonella</italic> Typhimurium was significantly higher in APH than in KATH (<italic>p</italic> = 0.011; Table <xref rid="Tab4" ref-type="table">4</xref>), however, <italic>Salmonella</italic> Enteritidis was isolated from only KATH.
<table-wrap id="Tab4"><label>Table 4</label><caption xml:lang="en"><p>Invasive NTS distribution among study population</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Serovar</p></th><th><p>KATH [n(%)]</p><p>(<italic>n</italic> = 9)</p></th><th><p>APH [n(%)]</p><p>(<italic>n</italic> = 7)</p></th><th><p><italic>p</italic>-value</p></th></tr></thead><tbody><tr><td><p><italic>Salmonella</italic> Typhimurium</p></td><td><p>3 (18.8)</p></td><td><p>7 (43.8)</p></td><td><p>0.011</p></td></tr><tr><td><p><italic>Salmonella</italic> Enteritidis</p></td><td><p>5 (31.1)</p></td><td><p>0</p></td><td><p>0.034</p></td></tr><tr><td><p>Untypable</p></td><td><p>1 (6.3)</p></td><td><p>0</p></td><td><p>–</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec25"><title>Antibiotic resistance profile</title><p id="Par52">Generally, first-line anti-<italic>Salmonella</italic> drugs (ampicillin, chloramphenicol, trimethoprim/sulfamethoxazole) recorded the highest rate of resistance in both <italic>S.</italic> Typhi and NTS isolates (between 33.8 and 50.0%). Third-generation cephalosporins (ceftazidime and ceftriaxone) and gentamicin had 100% efficacy rate in all serovars of <italic>Salmonella</italic> tested. Ciprofloxacin recorded significantly reduced susceptibility (intermediate) in both typhoidal and NTS (14.7 and 37.5%, respectively).</p></sec><sec id="Sec26"><title>MIC determination for resistant and reduced-susceptible <italic>Salmonella</italic> strains to fluoroquinolones</title><p id="Par53">Of the 20 ciprofloxacin intermediate/resistant <italic>Salmonella</italic> isolates tested by MIC, only 5 (breakpoint concentration between 0.12 and 0.5 μg/ml) were intermediate and no resistance recorded (Table <xref rid="Tab5" ref-type="table">5</xref>).
<table-wrap id="Tab5"><label>Table 5</label><caption xml:lang="en"><p>MIC of fluoroquinolone resistant and reduced-susceptible <italic>Salmonella</italic> strains</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Isolate number</p></th><th><p>MIC (μg/ml)</p></th><th><p>Interpretation</p></th></tr></thead><tbody><tr><td><p>16, 18</p></td><td><p>0.500</p></td><td><p>I</p></td></tr><tr><td><p>1, 14, 15</p></td><td><p>0.120</p></td><td><p>I</p></td></tr><tr><td><p>2, 5, 6, 8, 13, 17, 19, 20</p></td><td><p>0.030</p></td><td><p>S</p></td></tr><tr><td><p>3, 4, 7, 9, 10, 11, 12</p></td><td><p>0.015</p></td><td><p>S</p></td></tr></tbody></table><table-wrap-foot><p><italic>I</italic> intermediate, <italic>S</italic> sensitive</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec27"><title>Identification of mutations within QRDR</title><p id="Par54">Thirteen isolates were selected (based on MIC values from 0.03 to 0.5 μg/ml) for DNA product purification and subsequent sequencing prior to mutational analysis. Sequence analysis of <italic>gyrA</italic> gene revealed the presence of 5 different nonsynonymous mutations, with the most frequent mutation (Ile203Ser) occurring in 12 out of 13 isolates tested (Table <xref rid="Tab6" ref-type="table">6</xref>). Gyrase B (<italic>gyrB</italic>) gene revealed 1 nonsynonymous mutation in 3 out of 13 isolates, substituting amino acid phenylalanine with leucine at codon 601 (Phe601Leu). No mutation was observed in <italic>parC</italic> and <italic>parE</italic> genes. In <italic>gyrA</italic> mutation alone, Serovar Typhi recorded the highest mutation (5/13), followed by Typhimurium (4/13) and Enteritidis (4/13). All three isolates which harboured <italic>gyrB</italic> mutation were <italic>Salmonella</italic> Typhi. Again, 3 isolates, all <italic>S</italic>. Typhi possessed both <italic>gyrA</italic> and <italic>gyrB</italic> mutations. Only one <italic>S</italic>. Enteritidis isolate exhibited Lys154Asn <italic>gyrA</italic> mutation and 5 <italic>S</italic>. Typhi isolates had a Glu133Gly mutation in <italic>gyrA</italic> gene (Table <xref rid="Tab6" ref-type="table">6</xref>). The two isolates with the highest ciprofloxacin MIC (0.5 μg/ml) had common amino acid substitutions resulting in 1 nonsynonymous mutation in <italic>gyrA</italic> gene (Ile203Ser).
<table-wrap id="Tab6"><label>Table 6</label><caption xml:lang="en"><p>Summary of resistance profiles, target gene mutations and prevalence of PMQR genes</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"><p>Serovar</p></th><th rowspan="2"><p>Study site</p></th><th rowspan="2"><p>Cip MIC (μg/ml)</p></th><th rowspan="2"><p>Coresistance</p></th><th colspan="3"><p>Target mutations</p></th></tr><tr><th><p><italic>gyrA</italic></p></th><th><p><italic>gyrB</italic></p></th><th><p><italic>PMQR</italic></p></th></tr></thead><tbody><tr><td rowspan="3"><p>Typhi</p></td><td rowspan="3"><p>APH</p></td><td rowspan="3"><p>0.12</p></td><td rowspan="3"><p>AMPCSXTNATET</p></td><td><p><italic>Ser83Tyr</italic></p></td><td><p><italic>Phe601Leu</italic></p></td><td/></tr><tr><td><p><italic>Glu133Gly</italic></p></td><td/><td/></tr><tr><td><p><italic>Ile203Ser</italic></p></td><td/><td/></tr><tr><td rowspan="2"><p>Typhi</p></td><td rowspan="2"><p>APH</p></td><td rowspan="2"><p>0.03</p></td><td rowspan="2"><p>AMPCSXTTET</p></td><td><p><italic>Glu133Gly</italic></p></td><td><p><italic>Phe601Leu</italic></p></td><td/></tr><tr><td><p><italic>Ile203Ser</italic></p></td><td/><td/></tr><tr><td rowspan="2"><p>Typhi</p></td><td rowspan="2"><p>APH</p></td><td rowspan="2"><p>0.03</p></td><td rowspan="2"/><td><p><italic>Glu133Gly</italic></p></td><td/><td/></tr><tr><td><p><italic>Ile203Ser</italic></p></td><td/><td/></tr><tr><td rowspan="2"><p>Typhi</p></td><td rowspan="2"><p>APH</p></td><td rowspan="2"><p>0.03</p></td><td rowspan="2"/><td><p><italic>Glu133Gly</italic></p></td><td><p><italic>Phe601Leu</italic></p></td><td/></tr><tr><td><p><italic>Ile203Ser</italic></p></td><td/><td/></tr><tr><td rowspan="2"><p>Typhi</p></td><td rowspan="2"><p>APH</p></td><td rowspan="2"><p>0.03</p></td><td rowspan="2"/><td><p><italic>Glu133Gly</italic></p></td><td/><td/></tr><tr><td><p><italic>Ile203Ser</italic></p></td><td/><td/></tr><tr><td><p>Enteritidis</p></td><td><p>KATH</p></td><td><p>0.03</p></td><td><p>AMPCSXTTET</p></td><td><p><italic>Ile203Ser</italic></p></td><td/><td/></tr><tr><td rowspan="2"><p>Enteritidis</p></td><td rowspan="2"><p>KATH</p></td><td rowspan="2"><p>0.12</p></td><td rowspan="2"/><td><p><italic>Asp87Gly</italic></p></td><td/><td/></tr><tr><td><p><italic>Ile203Ser</italic></p></td><td/><td/></tr><tr><td rowspan="2"><p>Enteritidis</p></td><td rowspan="2"><p>KATH</p></td><td rowspan="2"><p>0.12</p></td><td rowspan="2"/><td><p><italic>Asp87Gly</italic></p></td><td/><td/></tr><tr><td><p><italic>Ile203Ser</italic></p></td><td/><td/></tr><tr><td><p>Enteritidis</p></td><td><p>KATH</p></td><td><p>0.50</p></td><td/><td><p><italic>Ile203Ser</italic></p></td><td/><td><p><italic>qnrS</italic></p></td></tr><tr><td><p>Typhimurium</p></td><td><p>APH</p></td><td><p>0.03</p></td><td/><td><p><italic>Ile203Ser</italic></p></td><td/><td/></tr><tr><td><p>Typhimurium</p></td><td><p>APH</p></td><td><p>0.50</p></td><td><p>AMPAMC</p></td><td><p><italic>Ile203Ser</italic></p></td><td/><td><p><italic>qnrS</italic></p></td></tr><tr><td><p>Typhimurium</p></td><td><p>APH</p></td><td><p>0.03</p></td><td><p>AMPAMC</p></td><td><p><italic>Lys154Asn</italic></p></td><td/><td/></tr><tr><td><p>Typhimurium</p></td><td><p>APH</p></td><td><p>0.03</p></td><td><p>AMPCSXTAMC</p></td><td><p><italic>Ile203Ser</italic></p></td><td/><td/></tr></tbody></table></table-wrap></p></sec><sec id="Sec28"><title>Detection of plasmid-mediated qnr genes</title><p id="Par55">Again, Of the 20 phenotypically resistant and/or intermediate <italic>Salmonella</italic> isolates to ciprofloxacin and nalidixic acid tested by singleplex PCR reactions, there was no amplification of <italic>qnrA</italic> and <italic>qnrB</italic> plasmid-mediated resistant genes. However, 2 isolates were found to harbour <italic>qnrS</italic> resistant gene of molecular size 550 bp (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Both isolates were non-typhoidal <italic>Salmonella</italic> strains from the blood (<italic>S.</italic> Enteritidis) and oropharynx (<italic>S.</italic> Typhimurium) of 11 and 1 year old children at KATH and APH, respectively. Again, these two isolates recorded the highest MIC value of 0.5 μg/ml (Table <xref rid="Tab6" ref-type="table">6</xref>).
<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>Amplification and detection of <italic>qnrS</italic> plasmid-mediated fluoroquinolone resistant gene (molecular size 550 bp) by PCR. Lanes 4,8 are positive for <italic>qnrS</italic> gene (550 bp). Lanes –C, +C are negative and positive controls respectively.L = Molecular ladder of size 100 bp</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12879_2019_4522_Fig2_HTML.png" id="MO2"/></p></fig></p></sec></sec><sec id="Sec29" sec-type="discussion"><title>Discussion</title><p id="Par56">This study identified five different <italic>gyrA</italic> mutations and one <italic>gyrB</italic> nonsynonymous mutation in quinolone-resistant <italic>Salmonella enterica</italic> from human clinical isolates. <italic>Salmonella</italic> isolates harbouring plasmid-mediated fluoroquinolone resistant gene <italic>qnrS</italic> was also identified in this study.</p><p id="Par57">There was high frequency of <italic>gyrA</italic> gene mutation in this study than the other topoisomerase genes examined. This agrees with findings from Eaves et al.<italic>,</italic> in that mutations occurring at the quinolone resistance determining regions of other topoisomerase genes are more uncommon than those observed in <italic>gyrA</italic> gene [<xref ref-type="bibr" rid="CR27">27</xref>]. Thus, there might be other mechanisms of resistance playing an important role, as mutations in all but <italic>gyrA</italic> gene were rare. In Africa, the most common mutation known to account for ciprofloxacin non-susceptibility in most clinical <italic>Salmonella</italic> isolates is found in <italic>gyrA</italic> gene, followed by <italic>parC</italic> and <italic>gyrB</italic> genes, with no reported case of <italic>parE</italic> gene mutation [<xref ref-type="bibr" rid="CR28">28</xref>]. As observed in this study, both <italic>parC</italic> and <italic>parE</italic> gene mutations were completely absent in the study populations, consistent with previous studies [<xref ref-type="bibr" rid="CR29">29</xref>]. Report by Bae et al., showed a higher frequency (18 out of 27 isolates) of <italic>gyrA</italic> mutation (Asp87Gly) in nalidixic acid resistant <italic>S</italic>. Enteritidis from South Korea [<xref ref-type="bibr" rid="CR30">30</xref>]. However, the present study identified only 2 nalidixic acid resistant <italic>S</italic>. Enteritidis with the same Asp87Gly <italic>gyrA</italic> mutation and had ciprofloxacin MIC 0.12 μg/ml. Codons 83 and 87 of <italic>gyrA</italic> gene are widely known to be a common hotspot for <italic>gyrA</italic> mutation [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>], nevertheless, their frequency was much lower in the current study. Mutations at these codons, especially codon 87, have been shown to be associated with decreased ciprofloxacin susceptibility and nalidixic acid resistance [<xref ref-type="bibr" rid="CR31">31</xref>].</p><p id="Par58">Other <italic>gyrA</italic> mutation was detected in 5 <italic>S</italic>. Typhi isolates which resulted in amino acid substitution from glutamic acid to glycine at codon 133 with MIC of 0.03 μg/ml (4 isolates) and 0.12 μg/ml (only one isolate). With these low MICs, it could be suggested that mutation of Glu133Gly alone could not necessarily lead to quinolone resistance in <italic>Salmonella</italic>. This agrees with findings from Eibach et al.<italic>,</italic> who detected a Glu133Gly mutation in ciprofloxacin susceptible <italic>S.</italic> Typhi clinical isolate in Ghana with MIC of 0.06 μg/ml [<xref ref-type="bibr" rid="CR29">29</xref>]. However, studies in Kenya found 11 <italic>S</italic>. Typhi reduced ciprofloxacin susceptible isolates with the same <italic>gyrA</italic> mutation (Glu133Gly) [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par59">Studies show that double mutations found in gyrase further reduce binding affinity of the enzyme-DNA complex to fluoroquinolones [<xref ref-type="bibr" rid="CR34">34</xref>]. This agrees with the current study as 2 <italic>S.</italic> Typhi isolates identified to have double mutations in <italic>gyrA</italic> and <italic>gyrB</italic> genes were MDR and also resistant to the quinolone nalidixic acid.</p><p id="Par60">Gyrase B gene mutation was detected in only 3 <italic>S</italic>. Typhi isolates which resulted in amino acid substitution from phenylalanine to leucine at codon 601 (Phe601leu). The first <italic>gyrB</italic> gene mutation (Glu466Asp) reported in Ghana was from <italic>S</italic>. Typhimurium [<xref ref-type="bibr" rid="CR15">15</xref>], however, the present study identified <italic>gyrB</italic> mutation in <italic>S</italic>. Typhi, for the first time in Ghana. Findings from Tadesse et al.<italic>,</italic> revealed a low proportion (0.2%) of <italic>Salmonella gyrB</italic> mutation from human and animal sources in Africa [<xref ref-type="bibr" rid="CR28">28</xref>].</p><p id="Par61">Molecular analysis by PCR detected the presence of quinolone resistance gene <italic>qnrS</italic> in 2 non-typhoidal <italic>Salmonella</italic> isolates from the blood and oropharynx in patients attending health care at KATH and APH respectively. The 3 principal genes responsible for plasmid-mediated fluoroquinolone resistance in <italic>Salmonella</italic> include <italic>qnrA, qnrB</italic> and <italic>qnrS</italic> genes [<xref ref-type="bibr" rid="CR9">9</xref>]. Previous studies in Ghana showed the absence of all three genes [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR29">29</xref>], indicating a more recent emergence of <italic>qnrS</italic> resistant gene. Plasmids increase bacterial genetic diversity greatly through acquisition or loss of genes especially, those pertaining to resistance and/or virulence. Detection of <italic>qnrS</italic> gene in this study might be due to indiscriminate use of over-the-counter antibiotics by humans, without complying to clinicians prescriptions. This could lead to increased selective pressure on the drugs and subsequently contributes to resistance. Again, there could be possibility of zoonotic transmission of these resistant genes [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>], as Dekker et al.<italic>,</italic> has already reported on emergence of <italic>qnrB</italic> resistant gene in poultry population in Ghana [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p id="Par62">Variant <italic>qnrA1</italic> of the <italic>qnrA</italic> gene family was the first plasmid-mediated fluoroquinolone resistant gene described, however, several studies show that this gene is not commonly found in <italic>Salmonella</italic> [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. This might explain why none of the isolates tested in this study was positive for <italic>qnrA</italic>.</p><p id="Par63">Dekker et al.<italic>,</italic> detected <italic>Salmonella</italic> Poona plasmid-mediated resistant gene <italic>qnrB2</italic> in 3 out of 200 poultry meat samples collected from markets in Ghana [<xref ref-type="bibr" rid="CR37">37</xref>]. In Africa, evidence-based findings of plasmid-encoded genetic determinants associated with fluoroquinolone resistance in <italic>Salmonella</italic> strains are generally rare [<xref ref-type="bibr" rid="CR28">28</xref>]. Few cases of <italic>qnrB</italic> and <italic>qnrS</italic> genes have been reported in South Africa [<xref ref-type="bibr" rid="CR40">40</xref>] and Nigeria [<xref ref-type="bibr" rid="CR8">8</xref>], respectively. Studies in Europe have reported on the increasing rate of <italic>qnrB</italic> resistant genes in several European countries (including Spain, Italy and Netherlands) and these were mostly from animal sources (predominantly chicken and turkey) [<xref ref-type="bibr" rid="CR41">41</xref>]. The most commonly reported <italic>qnrB</italic> variant is <italic>qnrB2</italic> and it is usually harboured in <italic>Salmonella</italic> serovars Agona, Derby, Enteritidis, Hadar, London and Montevideo [<xref ref-type="bibr" rid="CR41">41</xref>]. Although <italic>qnrB</italic> resistant genes are often restricted to animal populations, there is a potential chance of future global transmission to humans, as variant <italic>qnrB19</italic> has already been implicated in human <italic>S</italic>. Typhimurium infection in Netherlands and Italy [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Studies in Scotland also revealed the presence of <italic>qnrB</italic> and <italic>qnrS</italic> from returning travellers from Egypt and Nigeria [<xref ref-type="bibr" rid="CR39">39</xref>]. Another study conducted in United States reported on low prevalence of plasmid-mediated fluoroquinolone resistant genes, particularly <italic>qnrS</italic> [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. However, this study contrasts findings from some European (like Germany and Poland) and Asian countries, depicting regional differences in the prevalence of plasmid-mediated fluoroquinolone resistant genes [<xref ref-type="bibr" rid="CR45">45</xref>].</p><p id="Par64">To date, there are 9 variants of <italic>qnrS</italic> resistant gene (<italic>qnrS1 to qnrS9</italic>) identified, with <italic>qnrS1</italic> being the most predominant [<xref ref-type="bibr" rid="CR46">46</xref>]. Previous studies showed that <italic>qnrS1</italic> alone was capable of conferring reduced susceptibility to ciprofloxacin even in the absence of <italic>gyrA</italic> mutation [<xref ref-type="bibr" rid="CR47">47</xref>]. Again, findings from Hopkins et al.<italic>,</italic> in the United States demonstrated that quinolone resistant gene increased ciprofloxacin MIC to 0.38–0.78 μg/ml [<xref ref-type="bibr" rid="CR13">13</xref>], giving credence to the fact that, <italic>qnr</italic> genes might confer full resistance in the near future with MIC ≥1 μg/ml if strong surveillance system is not established to control spread of these plasmid-encoded genes.</p><p id="Par65">Other plasmid mediated fluoroquinolone resistant genes not screened in this study include <italic>qnrC, qnrD, qnrVC,</italic> aac(6′)-lb and plasmid-mediated enhanced efflux pump mechanisms by QepAB and OqxAB [<xref ref-type="bibr" rid="CR48">48</xref>]. Studies show that the global prevalence of these genes are low [<xref ref-type="bibr" rid="CR41">41</xref>]. Although <italic>qnr</italic> genes are usually associated with plasmid-encoded ESBL genes [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], no ESBL gene was identified among the <italic>qnrS</italic> positive strains in this study.</p><p id="Par66">Resistance of <italic>Salmonella</italic> to ciprofloxacin and other related fluoroquinolones has serious public health implications because this class of antimicrobials is commonly used to treat invasive forms of <italic>Salmonella</italic> infections. Mechanisms by these plasmid-mediated genetic determinants lead to low-level resistance that by itself does not exceed clinical breakpoint for susceptibility. However, it facilitates selection of higher level resistance and makes pathogens harbouring PMQR genes difficult to treat [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. The present study could not examine for the presence of other genetic determinants (such as <italic>qnrC, qnrD, qnrVC</italic>, <italic>aac(6′)-Ib-cr,</italic> and <italic>qepAB</italic> genes) responsible for plasmid-mediated fluoroquinolone resistance. Another limitation to this study was the inability to link the novel mutations (<italic>gyrA</italic> - Ile203Ser and Lys154Asn; and <italic>gyrB</italic> – Phe601Leu) to their involvement in reduced ciprofloxacin susceptibility/resistance within the QRDR. A suggested approach is to conduct a conjugational transfer experiment by introducing wild-type allele of the <italic>gyrA</italic> and <italic>gyrB</italic> genes into a broad host-range plasmid vector [<xref ref-type="bibr" rid="CR15">15</xref>].</p></sec><sec id="Sec30" sec-type="conclusions"><title>Conclusion</title><p id="Par67">This study reports for the first time plasmid-mediated fluoroquinolone resistant gene <italic>qnrS</italic> in <italic>Salmonella</italic> clinical isolates in Ghana. Nonsynonymous mutations (Asp87Gly, Glu133Gly and Ser83Tyr) which confer <italic>Salmonella</italic> reduced susceptibility to ciprofloxacin were also detected as reported in several studies [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>], with 3 other novel mutations likely to confer <italic>Salmonella</italic> resistance. We recommend surveillance systems to track the evolution of <italic>Salmonella</italic> plasmid-mediated resistant genes and to ensure proper use of antibiotics and control of severe infections.</p></sec></body><back><ack><title>Acknowledgements</title><p>We are thankful to the DNA Analysis Core Laboratory (Institute of Plant and Microbial Biology, Academia Sinica, Taipei, Taiwan) for providing Sanger sequencing service.</p></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>All authors have read and approved the manuscript. EOD, MO, YAS, FM, SEP conceptualised and designed the experiments. MO, AS, GA, HK, SC, CK performed the experiments. MO, GA, IO, SEP collected and analyzed the data. GA, MO wrote the paper. AO, IO, NS, CK, EOD, MO, AS, YAS, SEP critically reviewed the manuscript.</p></sec><sec><title>Funding</title><p>The report was generated as part of a large study investigating severe typhoid burden in Ghana. Core funding for this study was received from the Bill and Melinda Gates Foundation. Additional funding for laboratory reagents was received from the KNUST research excellence fund (KREF) (VC/ORG/15) and Academia Sinica (Taipei, Taiwan). The funding bodies played no role in design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></sec><sec sec-type="ethics-statement"><sec id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par68">Permission was sought from all patients and their relatives before samples were taken. Written informed consent was obtained from all participants of the study by means of signature and/or thumbprinting. Children older than 7 yrs. but younger than 18 yrs. gave their assent together with parental/guardian consent (written) before they were enrolled into the study. The main study protocol was reviewed and approved by the Committee for Human Research Publications and Ethics (CHRPE) at the School of Medical Sciences, Kwame Nkrumah University of Science and Technology (KNUST).</p></sec><sec id="FPar2"><title>Consent for publication</title><p id="Par69">Not applicable.</p></sec><sec id="FPar3" sec-type="COI-statement"><title>Competing interests</title><p id="Par70">The authors (including Florian Marks, who is an editorial board member for BMC Infectious Diseases) declare that they have no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mogasale</surname><given-names>V</given-names></name><name><surname>Maskery</surname><given-names>B</given-names></name><name><surname>Ochiai</surname><given-names>RL</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Mogasale</surname><given-names>VV</given-names></name><name><surname>Ramani</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>YE</given-names></name><name><surname>Park</surname><given-names>JK</given-names></name><name><surname>Wierzba</surname><given-names>TF</given-names></name></person-group><article-title xml:lang="en">Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment</article-title><source>Lancet Glob Health</source><year>2014</year><volume>2</volume><issue>10</issue><fpage>e570</fpage><lpage>e580</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(14)70301-8</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatavarthy</surname><given-names>A</given-names></name><name><surname>Luna</surname><given-names>VA</given-names></name><name><surname>Amuso</surname><given-names>PT</given-names></name></person-group><article-title xml:lang="en">How multidrug resistance in typhoid fever affects treatment options</article-title><source>Ann N Y Acad Sci</source><year>2014</year><volume>1323</volume><fpage>76</fpage><lpage>90</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXitV2gtrfJ</pub-id><pub-id pub-id-type="pmid">25069595</pub-id><pub-id pub-id-type="doi">10.1111/nyas.12490</pub-id><pub-id pub-id-type="pmcid">25069595</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SE</given-names></name><name><surname>Pham</surname><given-names>DT</given-names></name><name><surname>Boinett</surname><given-names>C</given-names></name><name><surname>Wong</surname><given-names>VK</given-names></name><name><surname>Pak</surname><given-names>GD</given-names></name><name><surname>Panzner</surname><given-names>U</given-names></name><name><surname>Espinoza</surname><given-names>LMC</given-names></name><name><surname>von Kalckreuth</surname><given-names>V</given-names></name><name><surname>Im</surname><given-names>J</given-names></name><name><surname>Schütt-Gerowitt</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">The phylogeography and incidence of multi-drug resistant typhoid fever in sub-Saharan Africa</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><issue>1</issue><fpage>5094</fpage><pub-id pub-id-type="pmid">30504848</pub-id><pub-id pub-id-type="pmcid">6269545</pub-id><pub-id pub-id-type="doi">10.1038/s41467-018-07370-z</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXisVakt7rK</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>VK</given-names></name><name><surname>Baker</surname><given-names>S</given-names></name><name><surname>Pickard</surname><given-names>DJ</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Page</surname><given-names>AJ</given-names></name><name><surname>Feasey</surname><given-names>NA</given-names></name><name><surname>Kingsley</surname><given-names>RA</given-names></name><name><surname>Thomson</surname><given-names>NR</given-names></name><name><surname>Keane</surname><given-names>JA</given-names></name><name><surname>Weill</surname><given-names>F-X</given-names></name></person-group><article-title xml:lang="en">Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter-and intracontinental transmission events</article-title><source>Nat Genet</source><year>2015</year><volume>47</volume><issue>6</issue><fpage>632</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXht1Wltb7O</pub-id><pub-id pub-id-type="pmid">4921243</pub-id><pub-id pub-id-type="pmcid">4921243</pub-id><pub-id pub-id-type="doi">10.1038/ng.3281</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>L-H</given-names></name><name><surname>Chiu</surname><given-names>C-H</given-names></name><name><surname>Chu</surname><given-names>C</given-names></name><name><surname>Ou</surname><given-names>JT</given-names></name></person-group><article-title xml:lang="en">Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge</article-title><source>Clin Infect Dis</source><year>2004</year><volume>39</volume><issue>4</issue><fpage>546</fpage><lpage>551</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXnslSjurk%3D</pub-id><pub-id pub-id-type="pmid">15356819</pub-id><pub-id pub-id-type="doi">10.1086/422726</pub-id><pub-id pub-id-type="pmcid">15356819</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills-Robertson</surname><given-names>F</given-names></name><name><surname>Addy</surname><given-names>ME</given-names></name><name><surname>Mensah</surname><given-names>P</given-names></name><name><surname>Crupper</surname><given-names>SS</given-names></name></person-group><article-title xml:lang="en">Molecular characterization of antibiotic resistance in clinical Salmonella typhi isolated in Ghana</article-title><source>FEMS Microbiol Lett</source><year>2002</year><volume>215</volume><issue>2</issue><fpage>249</fpage><lpage>253</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XotVKqsbg%3D</pub-id><pub-id pub-id-type="pmid">12399042</pub-id><pub-id pub-id-type="doi">10.1111/j.1574-6968.2002.tb11398.x</pub-id><pub-id pub-id-type="pmcid">12399042</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harish</surname><given-names>BN</given-names></name><name><surname>Menezes</surname><given-names>GA</given-names></name><name><surname>Sarangapani</surname><given-names>K</given-names></name><name><surname>Parija</surname><given-names>SC</given-names></name></person-group><article-title xml:lang="en">A case report and review of the literature: ciprofloxacin resistant Salmonella enterica serovar Typhi in India</article-title><source>J Infect Dev Ctries</source><year>2008</year><volume>2</volume><issue>04</issue><fpage>324</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">19741296</pub-id><pub-id pub-id-type="doi">10.3855/jidc.229</pub-id><pub-id pub-id-type="pmcid">19741296</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Cuypers WL, Jacobs J, Wong V, Klemm EJ, Deborggraeve S, Van Puyvelde S. Fluoroquinolone resistance in Salmonella: insights by whole-genome sequencing. Microb Genomics. 2018;4(7):1–9.</mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattoir</surname><given-names>V</given-names></name><name><surname>Weill</surname><given-names>F-X</given-names></name><name><surname>Poirel</surname><given-names>L</given-names></name><name><surname>Fabre</surname><given-names>L</given-names></name><name><surname>Soussy</surname><given-names>C-J</given-names></name><name><surname>Nordmann</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Prevalence of qnr genes in Salmonella in France</article-title><source>J Antimicrob Chemother</source><year>2007</year><volume>59</volume><issue>4</issue><fpage>751</fpage><lpage>754</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXltVKgsbs%3D</pub-id><pub-id pub-id-type="pmid">17307773</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkl547</pub-id><pub-id pub-id-type="pmcid">17307773</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robicsek</surname><given-names>A</given-names></name><name><surname>Jacoby</surname><given-names>GA</given-names></name><name><surname>Hooper</surname><given-names>DC</given-names></name></person-group><article-title xml:lang="en">The worldwide emergence of plasmid-mediated quinolone resistance</article-title><source>Lancet Infect Dis</source><year>2006</year><volume>6</volume><issue>10</issue><fpage>629</fpage><lpage>640</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XhtFChsbzF</pub-id><pub-id pub-id-type="pmid">17008172</pub-id><pub-id pub-id-type="doi">10.1016/S1473-3099(06)70599-0</pub-id><pub-id pub-id-type="pmcid">17008172</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldred</surname><given-names>KJ</given-names></name><name><surname>Kerns</surname><given-names>RJ</given-names></name><name><surname>Osheroff</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Mechanism of quinolone action and resistance</article-title><source>Biochemistry</source><year>2014</year><volume>53</volume><issue>10</issue><fpage>1565</fpage><lpage>1574</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXjt1ymtrk%3D</pub-id><pub-id pub-id-type="pmid">24576155</pub-id><pub-id pub-id-type="pmcid">3985860</pub-id><pub-id pub-id-type="doi">10.1021/bi5000564</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjölund-Karlsson</surname><given-names>M</given-names></name><name><surname>Howie</surname><given-names>R</given-names></name><name><surname>Rickert</surname><given-names>R</given-names></name><name><surname>Krueger</surname><given-names>A</given-names></name><name><surname>Tran</surname><given-names>T-T</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Ball</surname><given-names>T</given-names></name><name><surname>Haro</surname><given-names>J</given-names></name><name><surname>Pecic</surname><given-names>G</given-names></name><name><surname>Joyce</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Plasmid-mediated quinolone resistance among non-typhiSalmonella enterica isolates, USA</article-title><source>Emerg Infect Dis</source><year>2010</year><volume>16</volume><issue>11</issue><fpage>1789</fpage><pub-id pub-id-type="pmid">21029547</pub-id><pub-id pub-id-type="pmcid">3294515</pub-id><pub-id pub-id-type="doi">10.3201/eid1611.100464</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhsFWqtbnM</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopkins</surname><given-names>KL</given-names></name><name><surname>Day</surname><given-names>M</given-names></name><name><surname>Threlfall</surname><given-names>EJ</given-names></name></person-group><article-title xml:lang="en">Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom</article-title><source>Emerg Infect Dis</source><year>2008</year><volume>14</volume><issue>2</issue><fpage>340</fpage><pub-id pub-id-type="pmid">18258138</pub-id><pub-id pub-id-type="pmcid">2600194</pub-id><pub-id pub-id-type="doi">10.3201/eid1402.070573</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abgottspon</surname><given-names>H</given-names></name><name><surname>Zurfluh</surname><given-names>K</given-names></name><name><surname>Nüesch-Inderbinen</surname><given-names>M</given-names></name><name><surname>Hächler</surname><given-names>H</given-names></name><name><surname>Stephan</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Quinolone resistance mechanisms in Salmonella enterica serovars Hadar, Kentucky, Virchow, Schwarzengrund, and 4, 5, 12: i:−, isolated from humans in Switzerland, and identification of a novel qnrD variant, qnrD2, in S. Hadar</article-title><source>Antimicrob Agents Chemother</source><year>2014</year><volume>58</volume><issue>6</issue><fpage>3560</fpage><lpage>3563</lpage><pub-id pub-id-type="pmid">24733466</pub-id><pub-id pub-id-type="pmcid">4068464</pub-id><pub-id pub-id-type="doi">10.1128/AAC.02404-14</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhtlCntbrF</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Emran</surname><given-names>HM</given-names></name><name><surname>Heisig</surname><given-names>A</given-names></name><name><surname>Dekker</surname><given-names>D</given-names></name><name><surname>Adu-Sarkodie</surname><given-names>Y</given-names></name><name><surname>Cruz Espinoza</surname><given-names>LM</given-names></name><name><surname>Panzner</surname><given-names>U</given-names></name><name><surname>von Kalckreuth</surname><given-names>V</given-names></name><name><surname>Marks</surname><given-names>F</given-names></name><name><surname>Park</surname><given-names>SE</given-names></name><name><surname>Sarpong</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Detection of a novel gyrB mutation associated with fluoroquinolone-nonsusceptible <italic>Salmonella enterica</italic> serovar Typhimurium isolated from a bloodstream infection in Ghana</article-title><source>Clin Infect Dis</source><year>2016</year><volume>62</volume><issue>suppl_1</issue><fpage>S47</fpage><lpage>S49</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXitVCrt7c%3D</pub-id><pub-id pub-id-type="pmid">26933021</pub-id><pub-id pub-id-type="doi">10.1093/cid/civ790</pub-id><pub-id pub-id-type="pmcid">26933021</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldred</surname><given-names>KJ</given-names></name><name><surname>McPherson</surname><given-names>SA</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Kerns</surname><given-names>RJ</given-names></name><name><surname>Graves</surname><given-names>DE</given-names></name><name><surname>Turnbough</surname><given-names>CL</given-names><suffix>Jr</suffix></name><name><surname>Osheroff</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance</article-title><source>Biochemistry</source><year>2011</year><volume>51</volume><issue>1</issue><fpage>370</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">22126453</pub-id><pub-id pub-id-type="pmcid">3261753</pub-id><pub-id pub-id-type="doi">10.1021/bi2013905</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhsFCmsrbM</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnard</surname><given-names>FM</given-names></name><name><surname>Maxwell</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser83and Asp87</article-title><source>Antimicrob Agents Chemother</source><year>2001</year><volume>45</volume><issue>7</issue><fpage>1994</fpage><lpage>2000</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXks1Gksrs%3D</pub-id><pub-id pub-id-type="pmid">11408214</pub-id><pub-id pub-id-type="pmcid">90591</pub-id><pub-id pub-id-type="doi">10.1128/AAC.45.7.1994-2000.2001</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordmann</surname><given-names>P</given-names></name><name><surname>Poirel</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae</article-title><source>J Antimicrob Chemother</source><year>2005</year><volume>56</volume><issue>3</issue><fpage>463</fpage><lpage>469</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXpvFGqtbg%3D</pub-id><pub-id pub-id-type="pmid">16020539</pub-id><pub-id pub-id-type="doi">10.1093/jac/dki245</pub-id><pub-id pub-id-type="pmcid">16020539</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drlica</surname><given-names>K</given-names></name><name><surname>Hiasa</surname><given-names>H</given-names></name><name><surname>Kerns</surname><given-names>R</given-names></name><name><surname>Malik</surname><given-names>M</given-names></name><name><surname>Mustaev</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Quinolones: action and resistance updated</article-title><source>Curr Top Med Chem</source><year>2009</year><volume>9</volume><issue>11</issue><fpage>981</fpage><lpage>998</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhsFWisb%2FF</pub-id><pub-id pub-id-type="pmid">19747119</pub-id><pub-id pub-id-type="pmcid">3182077</pub-id><pub-id pub-id-type="doi">10.2174/156802609789630947</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuijpers</surname><given-names>LM</given-names></name><name><surname>Phe</surname><given-names>T</given-names></name><name><surname>Veng</surname><given-names>CH</given-names></name><name><surname>Lim</surname><given-names>K</given-names></name><name><surname>Ieng</surname><given-names>S</given-names></name><name><surname>Kham</surname><given-names>C</given-names></name><name><surname>Fawal</surname><given-names>N</given-names></name><name><surname>Fabre</surname><given-names>L</given-names></name><name><surname>Le Hello</surname><given-names>S</given-names></name><name><surname>Vlieghe</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015</article-title><source>PLoS Negl Trop Dis</source><year>2017</year><volume>11</volume><issue>9</issue><fpage>e0005964</fpage><pub-id pub-id-type="pmid">28931025</pub-id><pub-id pub-id-type="pmcid">5624643</pub-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0005964</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thanh</surname><given-names>DP</given-names></name><name><surname>Karkey</surname><given-names>A</given-names></name><name><surname>Dongol</surname><given-names>S</given-names></name><name><surname>Thi</surname><given-names>NH</given-names></name><name><surname>Thompson</surname><given-names>CN</given-names></name><name><surname>Rabaa</surname><given-names>MA</given-names></name><name><surname>Arjyal</surname><given-names>A</given-names></name><name><surname>Holt</surname><given-names>KE</given-names></name><name><surname>Wong</surname><given-names>V</given-names></name><name><surname>Thieu</surname><given-names>NTV</given-names></name></person-group><article-title xml:lang="en">A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failure</article-title><source>Elife</source><year>2016</year><volume>5</volume><fpage>e14003</fpage><pub-id pub-id-type="doi">10.7554/eLife.14003</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXmtlGgtLg%3D</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendriksen</surname><given-names>RS</given-names></name><name><surname>Leekitcharoenphon</surname><given-names>P</given-names></name><name><surname>Lukjancenko</surname><given-names>O</given-names></name><name><surname>Lukwesa-Musyani</surname><given-names>C</given-names></name><name><surname>Tambatamba</surname><given-names>B</given-names></name><name><surname>Mwaba</surname><given-names>J</given-names></name><name><surname>Kalonda</surname><given-names>A</given-names></name><name><surname>Nakazwe</surname><given-names>R</given-names></name><name><surname>Kwenda</surname><given-names>G</given-names></name><name><surname>Jensen</surname><given-names>JD</given-names></name></person-group><article-title xml:lang="en">Genomic signature of multidrug-resistant Salmonella enterica serovar Typhi isolates related to a massive outbreak in Zambia between 2010 and 2012</article-title><source>J Clin Microbiol</source><year>2015</year><volume>53</volume><issue>1</issue><fpage>262</fpage><lpage>272</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXpsVSjtQ%3D%3D</pub-id><pub-id pub-id-type="pmid">25392358</pub-id><pub-id pub-id-type="doi">10.1128/JCM.02026-14</pub-id><pub-id pub-id-type="pmcid">25392358</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Consortium</surname><given-names>IT</given-names></name><name><surname>Wong</surname><given-names>VK</given-names></name><name><surname>Holt</surname><given-names>KE</given-names></name><name><surname>Okoro</surname><given-names>C</given-names></name><name><surname>Baker</surname><given-names>S</given-names></name><name><surname>Pickard</surname><given-names>DJ</given-names></name><name><surname>Marks</surname><given-names>F</given-names></name><name><surname>Page</surname><given-names>AJ</given-names></name><name><surname>Olanipekun</surname><given-names>G</given-names></name><name><surname>Munir</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Molecular surveillance identifies multiple transmissions of typhoid in West Africa</article-title><source>PLoS Negl Trop Dis</source><year>2016</year><volume>10</volume><issue>9</issue><fpage>e0004781</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0004781</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXps1WhtLY%3D</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>CLSI</collab></person-group><source>Performance standards for antimicrobial susceptibility testing. CLSI supplement M100</source><year>2018</year><edition>28</edition><publisher-loc>Wayne</publisher-loc><publisher-name>Clinical and Laboratory Standards Institute</publisher-name></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Mutai WC. Characterization of antibiotic resistance plasmids in Salmonella enterica serovar Typhi isolated in Nairobi, Kenya. Med Microbiol. 2016:1–139.</mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chau</surname><given-names>TT</given-names></name><name><surname>Campbell</surname><given-names>JI</given-names></name><name><surname>Galindo</surname><given-names>CM</given-names></name><name><surname>Van Minh</surname><given-names>HN</given-names></name><name><surname>Diep</surname><given-names>TS</given-names></name><name><surname>Nga</surname><given-names>TT</given-names></name><name><surname>Van Vinh</surname><given-names>CN</given-names></name><name><surname>Tuan</surname><given-names>PQ</given-names></name><name><surname>Page</surname><given-names>AL</given-names></name><name><surname>Ochiai</surname><given-names>RL</given-names></name><etal/></person-group><article-title xml:lang="en">Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones</article-title><source>Antimicrob Agents Chemother</source><year>2007</year><volume>51</volume><issue>12</issue><fpage>4315</fpage><lpage>4323</lpage><pub-id pub-id-type="pmid">17908946</pub-id><pub-id pub-id-type="pmcid">2167998</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00294-07</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXhsVWisb%2FP</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eaves</surname><given-names>DJ</given-names></name><name><surname>Randall</surname><given-names>L</given-names></name><name><surname>Gray</surname><given-names>DT</given-names></name><name><surname>Buckley</surname><given-names>A</given-names></name><name><surname>Woodward</surname><given-names>MJ</given-names></name><name><surname>White</surname><given-names>AP</given-names></name><name><surname>Piddock</surname><given-names>LJ</given-names></name></person-group><article-title xml:lang="en">Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica</article-title><source>Antimicrob Agents Chemother</source><year>2004</year><volume>48</volume><issue>10</issue><fpage>4012</fpage><lpage>4015</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXosVygt78%3D</pub-id><pub-id pub-id-type="pmid">15388468</pub-id><pub-id pub-id-type="pmcid">521866</pub-id><pub-id pub-id-type="doi">10.1128/AAC.48.10.4012-4015.2004</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tadesse</surname><given-names>G</given-names></name><name><surname>Tessema</surname><given-names>TS</given-names></name><name><surname>Beyene</surname><given-names>G</given-names></name><name><surname>Aseffa</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Molecular epidemiology of fluoroquinolone resistant Salmonella in Africa: a systematic review and meta-analysis</article-title><source>PLoS One</source><year>2018</year><volume>13</volume><issue>2</issue><fpage>e0192575</fpage><pub-id pub-id-type="pmid">29432492</pub-id><pub-id pub-id-type="pmcid">5809059</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0192575</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhs1KqtbjL</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eibach</surname><given-names>D</given-names></name><name><surname>Al-Emran</surname><given-names>HM</given-names></name><name><surname>Dekker</surname><given-names>DM</given-names></name><name><surname>Krumkamp</surname><given-names>R</given-names></name><name><surname>Adu-Sarkodie</surname><given-names>Y</given-names></name><name><surname>Cruz Espinoza</surname><given-names>LM</given-names></name><name><surname>Ehmen</surname><given-names>C</given-names></name><name><surname>Boahen</surname><given-names>K</given-names></name><name><surname>Heisig</surname><given-names>P</given-names></name><name><surname>Im</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">The emergence of reduced ciprofloxacin susceptibility in <italic>Salmonella enterica</italic> causing bloodstream infections in rural Ghana</article-title><source>Clin Infect Dis</source><year>2016</year><volume>62</volume><issue>suppl_1</issue><fpage>S32</fpage><lpage>S36</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXitVCrt70%3D</pub-id><pub-id pub-id-type="pmid">26933017</pub-id><pub-id pub-id-type="doi">10.1093/cid/civ757</pub-id><pub-id pub-id-type="pmcid">26933017</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>DH</given-names></name><name><surname>Baek</surname><given-names>HJ</given-names></name><name><surname>Jeong</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name></person-group><article-title xml:lang="en">Amino acid substitutions in gyrA and parC associated with quinolone resistance in nalidixic acid-resistant Salmonella isolates</article-title><source>Ir Vet J</source><year>2013</year><volume>66</volume><issue>1</issue><fpage>23</fpage><pub-id pub-id-type="pmid">24237626</pub-id><pub-id pub-id-type="pmcid">4225662</pub-id><pub-id pub-id-type="doi">10.1186/2046-0481-66-23</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunguya</surname><given-names>O</given-names></name><name><surname>Lejon</surname><given-names>V</given-names></name><name><surname>Phoba</surname><given-names>M-F</given-names></name><name><surname>Bertrand</surname><given-names>S</given-names></name><name><surname>Vanhoof</surname><given-names>R</given-names></name><name><surname>Glupczynski</surname><given-names>Y</given-names></name><name><surname>Verhaegen</surname><given-names>J</given-names></name><name><surname>Muyembe-Tamfum</surname><given-names>J-J</given-names></name><name><surname>Jacobs</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Antimicrobial resistance in invasive non-typhoid Salmonella from the Democratic Republic of the Congo: emergence of decreased fluoroquinolone susceptibility and extended-spectrum beta lactamases</article-title><source>PLoS Negl Trop Dis</source><year>2013</year><volume>7</volume><issue>3</issue><fpage>e2103</fpage><pub-id pub-id-type="pmid">23516651</pub-id><pub-id pub-id-type="pmcid">3597487</pub-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0002103</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>E</given-names></name><name><surname>Lam</surname><given-names>A</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong</article-title><source>Antimicrob Agents Chemother</source><year>2003</year><volume>47</volume><issue>11</issue><fpage>3567</fpage><lpage>3573</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXovVaitLk%3D</pub-id><pub-id pub-id-type="pmid">14576119</pub-id><pub-id pub-id-type="pmcid">253778</pub-id><pub-id pub-id-type="doi">10.1128/AAC.47.11.3567-3573.2003</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Emran</surname><given-names>HM</given-names></name><name><surname>Eibach</surname><given-names>D</given-names></name><name><surname>Krumkamp</surname><given-names>R</given-names></name><name><surname>Ali</surname><given-names>M</given-names></name><name><surname>Baker</surname><given-names>S</given-names></name><name><surname>Biggs</surname><given-names>HM</given-names></name><name><surname>Bjerregaard-Andersen</surname><given-names>M</given-names></name><name><surname>Breiman</surname><given-names>RF</given-names></name><name><surname>Clemens</surname><given-names>JD</given-names></name><name><surname>Crump</surname><given-names>JA</given-names></name></person-group><article-title xml:lang="en">A multicountry molecular analysis of <italic>Salmonella enterica</italic> serovar Typhi with reduced susceptibility to ciprofloxacin in sub-Saharan Africa</article-title><source>Clin Infect Dis</source><year>2016</year><volume>62</volume><issue>suppl_1</issue><fpage>S42</fpage><lpage>S46</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXitVCrurc%3D</pub-id><pub-id pub-id-type="pmid">26933020</pub-id><pub-id pub-id-type="pmcid">4772832</pub-id><pub-id pub-id-type="doi">10.1093/cid/civ788</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zayed</surname><given-names>AA-F</given-names></name><name><surname>Essam</surname><given-names>TM</given-names></name><name><surname>Hashem</surname><given-names>A-GM</given-names></name><name><surname>El-Tayeb</surname><given-names>OM</given-names></name></person-group><article-title xml:lang="en">‘Supermutators’ found amongst highly levofloxacin-resistant E. coli isolates: a rapid protocol for the detection of mutation sites</article-title><source>Emerg Microb Infect</source><year>2015</year><volume>4</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/emi.2015.4</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhvVOmsbg%3D</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Threlfall</surname><given-names>EJ</given-names></name></person-group><article-title xml:lang="en">Antimicrobial drug resistance in Salmonella: problems and perspectives in food-and water-borne infections</article-title><source>FEMS Microbiol Rev</source><year>2002</year><volume>26</volume><issue>2</issue><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XksFymtLs%3D</pub-id><pub-id pub-id-type="pmid">12069879</pub-id><pub-id pub-id-type="doi">10.1111/j.1574-6976.2002.tb00606.x</pub-id><pub-id pub-id-type="pmcid">12069879</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andoh</surname><given-names>LA</given-names></name><name><surname>Dalsgaard</surname><given-names>A</given-names></name><name><surname>Obiri-Danso</surname><given-names>K</given-names></name><name><surname>Newman</surname><given-names>M</given-names></name><name><surname>Barco</surname><given-names>L</given-names></name><name><surname>Olsen</surname><given-names>JE</given-names></name></person-group><article-title xml:lang="en">Prevalence and antimicrobial resistance of Salmonella serovars isolated from poultry in Ghana</article-title><source>Epidemiol Infect</source><year>2016</year><volume>144</volume><issue>15</issue><fpage>3288</fpage><lpage>3299</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhvV2gtrzM</pub-id><pub-id pub-id-type="pmid">27334298</pub-id><pub-id pub-id-type="doi">10.1017/S0950268816001126</pub-id><pub-id pub-id-type="pmcid">27334298</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dekker</surname><given-names>Denise</given-names></name><name><surname>Eibach</surname><given-names>Daniel</given-names></name><name><surname>Boahen</surname><given-names>Kennedy G.</given-names></name><name><surname>Akenten</surname><given-names>Charity Wiafe</given-names></name><name><surname>Pfeifer</surname><given-names>Yvonne</given-names></name><name><surname>Zautner</surname><given-names>Andreas E.</given-names></name><name><surname>Mertens</surname><given-names>Eva</given-names></name><name><surname>Krumkamp</surname><given-names>Ralf</given-names></name><name><surname>Jaeger</surname><given-names>Anna</given-names></name><name><surname>Flieger</surname><given-names>Antje</given-names></name><name><surname>Owusu-Dabo</surname><given-names>Ellis</given-names></name><name><surname>May</surname><given-names>Jürgen</given-names></name></person-group><article-title xml:lang="en">Fluoroquinolone-Resistant Salmonella enterica, Campylobacter spp., and Arcobacter butzleri from Local and Imported Poultry Meat in Kumasi, Ghana</article-title><source>Foodborne Pathogens and Disease</source><year>2019</year><volume>16</volume><issue>5</issue><fpage>352</fpage><lpage>358</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1MXptFamtLc%3D</pub-id><pub-id pub-id-type="pmid">30907631</pub-id><pub-id pub-id-type="pmcid">6529854</pub-id><pub-id pub-id-type="doi">10.1089/fpd.2018.2562</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunell</surname><given-names>M</given-names></name><name><surname>Webber</surname><given-names>MA</given-names></name><name><surname>Kotilainen</surname><given-names>P</given-names></name><name><surname>Lilly</surname><given-names>AJ</given-names></name><name><surname>Caddick</surname><given-names>JM</given-names></name><name><surname>Jalava</surname><given-names>J</given-names></name><name><surname>Huovinen</surname><given-names>P</given-names></name><name><surname>Siitonen</surname><given-names>A</given-names></name><name><surname>Hakanen</surname><given-names>AJ</given-names></name><name><surname>Piddock</surname><given-names>LJ</given-names></name></person-group><article-title xml:lang="en">Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype</article-title><source>Antimicrob Agents Chemother</source><year>2009</year><volume>53</volume><issue>9</issue><fpage>3832</fpage><lpage>3836</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhtFCjsrzO</pub-id><pub-id pub-id-type="pmid">19596880</pub-id><pub-id pub-id-type="pmcid">2737843</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00121-09</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>A</given-names></name><name><surname>Mather</surname><given-names>H</given-names></name><name><surname>Coia</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Plasmid-mediated quinolone resistance in nalidixic-acid-susceptible strains of Salmonella enterica isolated in Scotland</article-title><source>J Antimicrob Chemother</source><year>2008</year><volume>62</volume><issue>5</issue><fpage>1153</fpage><lpage>1155</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXht1eksrbL</pub-id><pub-id pub-id-type="pmid">18779257</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkn340</pub-id><pub-id pub-id-type="pmcid">18779257</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govender</surname><given-names>N</given-names></name><name><surname>Smith</surname><given-names>AM</given-names></name><name><surname>Karstaedt</surname><given-names>AS</given-names></name><name><surname>Keddy</surname><given-names>KH</given-names></name></person-group><article-title xml:lang="en">Plasmid-mediated quinolone resistance in Salmonella from South Africa</article-title><source>J Med Microbiol</source><year>2009</year><volume>58</volume><issue>10</issue><fpage>1393</fpage><lpage>1394</lpage><pub-id pub-id-type="pmid">19541785</pub-id><pub-id pub-id-type="doi">10.1099/jmm.0.009621-0</pub-id><pub-id pub-id-type="pmcid">19541785</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veldman</surname><given-names>K</given-names></name><name><surname>Cavaco</surname><given-names>LM</given-names></name><name><surname>Mevius</surname><given-names>D</given-names></name><name><surname>Battisti</surname><given-names>A</given-names></name><name><surname>Franco</surname><given-names>A</given-names></name><name><surname>Botteldoorn</surname><given-names>N</given-names></name><name><surname>Bruneau</surname><given-names>M</given-names></name><name><surname>Perrin-Guyomard</surname><given-names>A</given-names></name><name><surname>Cerny</surname><given-names>T</given-names></name><name><surname>De Frutos</surname><given-names>EC</given-names></name></person-group><article-title xml:lang="en">International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries</article-title><source>J Antimicrob Chemother</source><year>2011</year><volume>66</volume><issue>6</issue><fpage>1278</fpage><lpage>1286</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXmt1aisL4%3D</pub-id><pub-id pub-id-type="pmid">21393198</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkr084</pub-id><pub-id pub-id-type="pmcid">21393198</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Fernández</surname><given-names>A</given-names></name><name><surname>Fortini</surname><given-names>D</given-names></name><name><surname>Veldman</surname><given-names>K</given-names></name><name><surname>Mevius</surname><given-names>D</given-names></name><name><surname>Carattoli</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella</article-title><source>J Antimicrob Chemother</source><year>2008</year><volume>63</volume><issue>2</issue><fpage>274</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">19001452</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkn470</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXit1KnsbY%3D</pub-id><pub-id pub-id-type="pmcid">19001452</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dionisi</surname><given-names>AM</given-names></name><name><surname>Graziani</surname><given-names>C</given-names></name><name><surname>Lucarelli</surname><given-names>C</given-names></name><name><surname>Filetici</surname><given-names>E</given-names></name><name><surname>Villa</surname><given-names>L</given-names></name><name><surname>Owczarek</surname><given-names>S</given-names></name><name><surname>Caprioli</surname><given-names>A</given-names></name><name><surname>Luzzi</surname><given-names>I</given-names></name></person-group><article-title xml:lang="en">Molecular characterization of multidrug-resistant strains of Salmonella enterica serotype Typhimurium and monophasic variant (S. 4,[5], 12: i:–) isolated from human infections in Italy</article-title><source>Foodborne Pathog Dis</source><year>2009</year><volume>6</volume><issue>6</issue><fpage>711</fpage><lpage>717</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXovVSgsr0%3D</pub-id><pub-id pub-id-type="pmid">19580448</pub-id><pub-id pub-id-type="doi">10.1089/fpd.2008.0240</pub-id><pub-id pub-id-type="pmcid">19580448</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frye</surname><given-names>JG</given-names></name><name><surname>Jackson</surname><given-names>CR</given-names></name></person-group><article-title xml:lang="en">Genetic mechanisms of antimicrobial resistance identified in <italic>Salmonella enterica</italic>, <italic>Escherichia coli</italic>, and Enteroccocus spp. isolated from US food animals</article-title><source>Front Microbiol</source><year>2013</year><volume>4</volume><fpage>135</fpage><pub-id pub-id-type="pmid">23734150</pub-id><pub-id pub-id-type="pmcid">3661942</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2013.00135</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavaco</surname><given-names>L</given-names></name><name><surname>Korsgaard</surname><given-names>H</given-names></name><name><surname>Sørensen</surname><given-names>G</given-names></name><name><surname>Aarestrup</surname><given-names>FM</given-names></name></person-group><article-title xml:lang="en">Plasmid-mediated quinolone resistance due to qnrB5 and qnrS1 genes in Salmonella enterica serovars Newport, Hadar and Saintpaul isolated from Turkey meat in Denmark</article-title><source>J Antimicrob Chemother</source><year>2008</year><volume>62</volume><issue>3</issue><fpage>632</fpage><lpage>634</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhtVShsr3L</pub-id><pub-id pub-id-type="pmid">18495652</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkn211</pub-id><pub-id pub-id-type="pmcid">18495652</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colomer-Lluch</surname><given-names>M</given-names></name><name><surname>Jofre</surname><given-names>J</given-names></name><name><surname>Muniesa</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Quinolone resistance genes (qnrA and qnrS) in bacteriophage particles from wastewater samples and the effect of inducing agents on packaged antibiotic resistance genes</article-title><source>J Antimicrob Chemother</source><year>2014</year><volume>69</volume><issue>5</issue><fpage>1265</fpage><lpage>1274</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXls1Ogu78%3D</pub-id><pub-id pub-id-type="pmid">24458509</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkt528</pub-id><pub-id pub-id-type="pmcid">24458509</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopkins</surname><given-names>KL</given-names></name><name><surname>Wootton</surname><given-names>L</given-names></name><name><surname>Day</surname><given-names>MR</given-names></name><name><surname>Threlfall</surname><given-names>EJ</given-names></name></person-group><article-title xml:lang="en">Plasmid-mediated quinolone resistance determinant qnrS1 found in Salmonella enterica strains isolated in the UK</article-title><source>J Antimicrob Chemother</source><year>2007</year><volume>59</volume><issue>6</issue><fpage>1071</fpage><lpage>1075</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXnvVahsrk%3D</pub-id><pub-id pub-id-type="pmid">17434878</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkm081</pub-id><pub-id pub-id-type="pmcid">17434878</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jacoby</surname><given-names>George A.</given-names></name></person-group><article-title>Plasmid-Mediated Quinolone Resistance</article-title><source>Antimicrobial Drug Resistance</source><year>2017</year><publisher-loc>Cham</publisher-loc><publisher-name>Springer International Publishing</publisher-name><fpage>265</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-46718-4_17</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martínez-Martínez</surname><given-names>L</given-names></name><name><surname>Pascual</surname><given-names>A</given-names></name><name><surname>Jacoby</surname><given-names>GA</given-names></name></person-group><article-title xml:lang="en">Quinolone resistance from a transferable plasmid</article-title><source>Lancet</source><year>1998</year><volume>351</volume><issue>9105</issue><fpage>797</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">9519952</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(97)07322-4</pub-id><pub-id pub-id-type="pmcid">9519952</pub-id></mixed-citation></ref></ref-list></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>APH</term><def><p id="Par5">Agogo Presbyterian Hospital</p></def></def-item><def-item><term>BA</term><def><p id="Par6">Blood Agar</p></def></def-item><def-item><term>CA</term><def><p id="Par7">Chocolate Agar</p></def></def-item><def-item><term>CHRPE</term><def><p id="Par8">Committee for Human Research Publication and Ethics</p></def></def-item><def-item><term>CLSI</term><def><p id="Par9">Clinical and Laboratory Standards Institute</p></def></def-item><def-item><term>EBI</term><def><p id="Par10">European Bioinformatics Institute</p></def></def-item><def-item><term>ESBL</term><def><p id="Par11">Extended Spectrum Beta-lactamase</p></def></def-item><def-item><term>ExPASY</term><def><p id="Par12">Expert Protein Analysis System</p></def></def-item><def-item><term>KATH</term><def><p id="Par13">Komfo Anokye Teaching Hospital</p></def></def-item><def-item><term>KCCR</term><def><p id="Par14">Kumasi Centre for Collaborative Research in Tropical Medicine</p></def></def-item><def-item><term>KNUST</term><def><p id="Par15">Kwame Nkrumah University of Science and Technology</p></def></def-item><def-item><term>MIC</term><def><p id="Par16">Minimum Inhibitory Concentration</p></def></def-item><def-item><term>MRSA</term><def><p id="Par17">Methicillin-resistant <italic>Staphylococcus aureus</italic></p></def></def-item><def-item><term>PCR</term><def><p id="Par18">Polymerase Chain Reaction</p></def></def-item><def-item><term>PMQR</term><def><p id="Par19">Plasmid-mediated Quinolone Resistance</p></def></def-item><def-item><term>QRDR</term><def><p id="Par20">Quinolone Resistance Determining Region</p></def></def-item><def-item><term>SIB</term><def><p id="Par21">Swiss Institute of Bioinformatics</p></def></def-item><def-item><term>TSI</term><def><p id="Par22">Triple Sugar Iron Agar</p></def></def-item><def-item><term>WHO</term><def><p id="Par23">World Health Organisation</p></def></def-item></def-list></glossary><notes notes-type="Misc"><title>Publisher’s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Infectious Diseases</facet-value><facet-value count="1">Internal Medicine</facet-value><facet-value count="1">Medical Microbiology</facet-value><facet-value count="1">Medicine &amp; Public Health</facet-value><facet-value count="1">Parasitology</facet-value><facet-value count="1">Tropical Medicine</facet-value></facet><facet name="keyword"><facet-value count="1">
                Salmonella enterica
              </facet-value><facet-value count="1">Fluoroquinolone resistance</facet-value><facet-value count="1">Mutations</facet-value><facet-value count="1">Plasmids</facet-value></facet><facet name="pub"><facet-value count="1">BMC Infectious Diseases</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">Ghana</facet-value><facet-value count="1">South Korea</facet-value><facet-value count="1">Taiwan</facet-value><facet-value count="1">Vietnam</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
